Validation of the TRAIN-AI for the Risk of HCC Recurrence After Liver Transplantation

CompletedOBSERVATIONAL
Enrollment

1,769

Participants

Timeline

Start Date

January 1, 2003

Primary Completion Date

January 1, 2003

Study Completion Date

December 31, 2018

Conditions
Hepatocellular Carcinoma (HCC)Liver TransplantationDeep Learning Model
Interventions
PROCEDURE

liver transplantation

Liver transplantation or hepatic transplantation is the replacement of a diseased liver with the healthy liver from another person (allograft). Liver transplantation is a treatment option for end-stage liver disease and acute liver failure, although availability of donor organs is a major limitation. Liver transplantation is highly regulated, and only performed at designated transplant medical centers by highly trained transplant physicians. Favorable outcomes require careful screening for eligible recipients, as well as a well-calibrated live or deceased donor match.

All Listed Sponsors
lead

European Hepatocellular Cancer Liver Transplant Group

OTHER

NCT06799468 - Validation of the TRAIN-AI for the Risk of HCC Recurrence After Liver Transplantation | Biotech Hunter | Biotech Hunter